Amplicore

Amplicore is a biopharmaceutical company developing injectable products for the treatment of degenerative musculoskeletal diseases to meet medical needs. Unlike current treatment methods, we adopt a regenerative approach to osteoarthritis, cartilage injury, degenerative disc disease, and acute meniscus tears. We are committed to addressing the root causes of joint discomfort, beyond merely alleviating pain. Our mission is to transform scientific innovation into effective minimally invasive products that can be easily delivered to patients. The company is currently conducting preclinical development of AM3101 and AM1101, aimed at reducing joint OA pain, inhibiting cartilage degradation, and promoting tissue regeneration of abnormal cartilage associated with the disease.